ATE495730T1 - Alkaloid-formulierungen - Google Patents

Alkaloid-formulierungen

Info

Publication number
ATE495730T1
ATE495730T1 AT05706340T AT05706340T ATE495730T1 AT E495730 T1 ATE495730 T1 AT E495730T1 AT 05706340 T AT05706340 T AT 05706340T AT 05706340 T AT05706340 T AT 05706340T AT E495730 T1 ATE495730 T1 AT E495730T1
Authority
AT
Austria
Prior art keywords
alkaloid
alkaloid formulations
formulations
alkaloids
reaction product
Prior art date
Application number
AT05706340T
Other languages
English (en)
Inventor
Simon West
Esra Ogru
Robert Gianello
Original Assignee
Vital Health Sciences Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004901107A external-priority patent/AU2004901107A0/en
Application filed by Vital Health Sciences Pty Ltd filed Critical Vital Health Sciences Pty Ltd
Application granted granted Critical
Publication of ATE495730T1 publication Critical patent/ATE495730T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05706340T 2004-03-03 2005-03-03 Alkaloid-formulierungen ATE495730T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2004901107A AU2004901107A0 (en) 2004-03-03 Alkaloid formulation
AU2004904367A AU2004904367A0 (en) 2004-08-03 Alkaloid formulations
PCT/AU2005/000307 WO2005084678A1 (en) 2004-03-03 2005-03-03 Alkaloid formulations

Publications (1)

Publication Number Publication Date
ATE495730T1 true ATE495730T1 (de) 2011-02-15

Family

ID=34921028

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05706340T ATE495730T1 (de) 2004-03-03 2005-03-03 Alkaloid-formulierungen

Country Status (14)

Country Link
US (2) US20060281716A1 (de)
EP (1) EP1720551B9 (de)
JP (1) JP4847437B2 (de)
KR (1) KR101173159B1 (de)
AT (1) ATE495730T1 (de)
AU (1) AU2005202477B2 (de)
BR (1) BRPI0508125A (de)
CA (1) CA2557354C (de)
DE (1) DE602005025979D1 (de)
DK (1) DK1720551T3 (de)
IL (1) IL177781A (de)
NZ (1) NZ549567A (de)
RU (1) RU2477136C2 (de)
WO (1) WO2005084678A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
ATE444756T1 (de) * 2000-11-14 2009-10-15 Vital Health Sciences Pty Ltd Zusammensetzungen umfassend komplexe von tocopherolphosphatderivaten
WO2003011303A1 (en) * 2001-07-27 2003-02-13 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
CA2466536C (en) * 2001-12-13 2012-02-07 Vital Health Sciences Pty Ltd Transdermal transport of compounds
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
WO2004064831A1 (en) * 2003-01-17 2004-08-05 Vital Health Sciences Pty Ltd Compounds having anti-proliferative properties
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
DK1720551T3 (da) 2004-03-03 2011-05-16 Vital Health Sciences Pty Ltd Alkaloidformuleringer
CA2575587C (en) * 2004-08-03 2014-06-17 Vital Health Sciences Pty Ltd Carrier for enteral administration
US20090239827A1 (en) * 2005-03-03 2009-09-24 Esra Ogru Compounds having lipid lowering properties
CA2599424A1 (en) * 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
NZ565049A (en) 2005-06-17 2012-02-24 Vital Health Sciences Pty Ltd A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
US20090005348A1 (en) * 2005-12-23 2009-01-01 Vital Health Sciences Pty Ltd Compounds Having Cytokine Modulating Properties
ES2999020T3 (en) 2010-02-05 2025-02-24 Phosphagenics Ltd Carrier comprising non-neutralised tocopheryl phosphate
EP2552486B1 (de) 2010-03-30 2020-08-12 Phosphagenics Limited Pflaster für transdermale verabreichung
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
US10402738B2 (en) 2012-12-03 2019-09-03 National Ict Australia Limited Bayesian nonparametric method for infrastructure failure prediction
TWI685497B (zh) * 2014-06-02 2020-02-21 西班牙商伊史帝夫製藥公司 具有多重模式抗疼痛活性的１-氧雜-４,９-二氮雜螺十一烷化合物之烷基衍生物
AR106697A1 (es) 2015-11-16 2018-02-07 Esteve Labor Dr Compuestos oxadiazoespíricos para el tratamiento del abuso y la adicción a las drogas
KR20190032265A (ko) * 2015-12-09 2019-03-27 포스파제닉스 리미티드 약제학적 제형
CN114712308A (zh) * 2015-12-09 2022-07-08 磷肌酸有限公司 药物制剂
EP3558903B1 (de) 2016-12-21 2024-07-03 Avecho Biotechnology Limited Verfahren zur phosphorylierung eines komplexen alkohols
CN116583272A (zh) 2020-10-19 2023-08-11 埃维科生物技术有限公司 包含生育酚磷酸酯和长链甘油三酯或长链脂肪酸的口服大麻素制剂
WO2022082257A1 (en) 2020-10-19 2022-04-28 Avecho Biotechnology Limited Oral cannabinoid formulation comprising medium chain triglycerides and tocopheryl phosphates
US12059486B2 (en) 2021-01-13 2024-08-13 Rodan &Fields, LLC Cosmetic compositions

Family Cites Families (182)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2407823A (en) * 1946-09-17 Antihemorrhagic esters and methods
US2667479A (en) * 1951-01-30 1954-01-26 Merck & Co Inc Benzimidazole phosphate
GB778142A (en) 1953-11-20 1957-07-03 Leo Ab High-molecular weight derivatives of hydroxyl group-containing steroids and a method of producing them
US2913477A (en) * 1957-03-22 1959-11-17 Merck & Co Inc Antihemorrhagic compounds and processes for preparing the same
US3127434A (en) * 1959-10-20 1964-03-31 Hoffmann La Roche Dihydrovitamin k monophosphate compounds and preparation thereof
US3212901A (en) * 1961-06-07 1965-10-19 Eastman Kodak Co Stabilized tocopherol concentrates and process for preparing the same
US3331896A (en) 1964-09-15 1967-07-18 Gen Aniline & Film Corp Method of preparing alkali soluble phosphate esters of hydroxylic organic compounds
US3607765A (en) * 1968-11-29 1971-09-21 Colgate Polmolive Co Detergent softener compositions
DE2526938C2 (de) * 1975-02-14 1982-04-22 F. Hoffmann-La Roche & Co. AG, 4002 Basel Vitaminpräparate
US4141938A (en) * 1976-10-07 1979-02-27 Hoechst Aktiengesellschaft Production of acid orthophosphoric acid ester mixtures
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
US4299906A (en) * 1979-06-01 1981-11-10 American Hoechst Corporation Light-sensitive color proofing film with surfactant in a light-sensitive coating
SU925961A1 (ru) 1980-08-15 1982-05-07 Московский ордена Трудового Красного Знамени технологический институт пищевой промышленности Способ получени фосфорилированных глицеридов высших жирных кислот
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
IT1157269B (it) * 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
CH661438A5 (it) * 1984-04-09 1987-07-31 Seuref Ag Composizioni farmaceutiche ad azione antianossica e metabolica cerebrale.
US4977282A (en) * 1984-04-17 1990-12-11 Henkel Corporation Production of d-alpha-tocopherol from natural plant sources
US4603142A (en) * 1984-06-01 1986-07-29 Wisconsin Alumni Research Foundation Cholesterol lowering method of use
EP0171009B1 (de) 1984-08-02 1991-05-22 HENKEL CORPORATION (a Delaware corp.) Reinigung von Tocopherolen durch Extraktion
JPS6191137A (ja) * 1984-10-11 1986-05-09 Kao Corp 外用薬剤組成物
JPH0781138B2 (ja) 1986-12-02 1995-08-30 株式会社資生堂 抗酸化剤
DE3702766A1 (de) * 1987-01-30 1988-08-11 Henkel Kgaa Verfahren zur herstellung und isolierung von monoalkylphosphorsaeureestern
JP3070744B2 (ja) * 1987-04-10 2000-07-31 株式会社日立製作所 ベクトル処理装置
US4952495A (en) * 1987-06-08 1990-08-28 Eastman Kodak Company Hydrolyzable compounds which release electron transfer agents and analytical use of same
PH25859A (en) 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3813624A1 (de) 1988-04-22 1989-11-02 Basf Ag Verfahren zur herstellung von d-(alpha)-tocopherol aus natuerlichen vorprodukten
CA2007643A1 (en) 1989-02-01 1990-08-01 Donald S. Karanewsky Combination of an hmg coa reductase inhibitor and a squalene synthetase inhibitor and method for lowering serum cholesterol using such combination
US6028105A (en) * 1989-04-06 2000-02-22 Nigra; Thomas P. Topical drug delivery composition and method
US5053222A (en) * 1989-06-07 1991-10-01 Shiseido Company Ltd. Hair cosmetic composition
US5094848A (en) 1989-06-30 1992-03-10 Neorx Corporation Cleavable diphosphate and amidated diphosphate linkers
DE3927113C2 (de) * 1989-08-17 1993-11-25 Dolorgiet Gmbh & Co Kg Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
JP2854631B2 (ja) 1989-11-21 1999-02-03 千寿製薬株式会社 糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤
IT1236843B (it) * 1989-11-22 1993-04-21 Simes Processo per la preparazione di 4-0-fosfati di dopamina o suoi derivati
JPH03206089A (ja) 1990-01-05 1991-09-09 Eisai Co Ltd 新規ビタミンｅ誘導体及びその製造方法
US5374645A (en) * 1990-01-22 1994-12-20 Ciba-Geigy Corporation Transdermal administation of ionic pharmaceutically active agents via aqueous isopropanol
FR2657526B1 (fr) * 1990-01-31 1994-10-28 Lvmh Rech Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues.
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
US5114957A (en) 1990-05-08 1992-05-19 Biodor U.S. Holding Tocopherol-based antiviral agents and method of using same
US5591772A (en) * 1991-11-22 1997-01-07 Lipogenics, Inc. Tocotrienols and tocotrienol-like compounds and methods for their use
SE9003665D0 (sv) * 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
FR2679904A1 (fr) * 1991-08-01 1993-02-05 Lvmh Rech Utilisation d'un phosphate de tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, ou pharmaceutiques et compositions ainsi obtenues.
US5643597A (en) * 1991-08-01 1997-07-01 Lvmh Recherche Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained
EP0535283A1 (de) 1991-10-02 1993-04-07 Merrell Dow Pharmaceuticals Inc. Tocopherol Analoge mit kardioprotektiver Wirkung
US5474891A (en) * 1991-10-30 1995-12-12 Thomas Jefferson University Plasma-based platelet concentrate preparations with additive
AU669492B2 (en) 1991-11-11 1996-06-13 Hisamitsu Pharmaceutical Co., Inc. Fomentation containing ketorolac
US5282312A (en) * 1991-12-31 1994-02-01 Tessera, Inc. Multi-layer circuit construction methods with customization features
JP3202775B2 (ja) * 1992-01-29 2001-08-27 エスエス製薬株式会社 固形製剤
JP3207494B2 (ja) * 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
JPH05286848A (ja) 1992-04-10 1993-11-02 Senju Pharmaceut Co Ltd 浴用剤
GB9212450D0 (en) 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
US5741518A (en) * 1992-08-03 1998-04-21 L'oreal Composition composed of an aqueous dispersion of stabilized vesicles of nonionic amphiphilic lipids
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
AU5171293A (en) * 1992-10-14 1994-05-09 Regents Of The University Of Colorado, The Ion-pairing of drugs for improved efficacy and delivery
US5348357A (en) 1992-12-24 1994-09-20 General Motors Corporation Vehicle closure latch having plastic coated ratchet
US6384043B1 (en) * 1993-02-01 2002-05-07 Gholam A. Peyman Methods of alleviating pain sensations of the denuded eye with opioid analgesics
TW252918B (de) * 1993-03-31 1995-08-01 Senju Pharma Co
GB9318271D0 (en) 1993-09-03 1993-10-20 Scotia Holdings Plc Tocopherols
CA2129509A1 (en) 1993-09-10 1995-03-11 Kazumi Ogata Pharmaceutical composition for renal disorder and a dialysis solution for extracorporeal hemodialysis
CA2176743A1 (en) * 1993-11-27 1995-06-01 Brian Christopher Challis Compositions comprising iminium ion scavengers and/or nitrite scavengers
JPH07196516A (ja) 1993-12-29 1995-08-01 Senju Pharmaceut Co Ltd 痔疾患治療剤
FR2714595B1 (fr) * 1993-12-30 1996-02-02 Oreal Emulsion eau dans huile contenant du rétinol, son utilisation et son conditionnement.
FR2715565B1 (fr) * 1994-01-31 1996-03-15 Oreal Composition cosmétique ou dermatologique stabilisée contenant plusieurs précurseurs d'un même actif pour maximaliser sa libération, son utilisation.
US5444957A (en) * 1994-02-01 1995-08-29 Roberts; Walter R. Multistory slab construction
EP0669132A1 (de) 1994-02-23 1995-08-30 van der Kraaij, Antonius Marinus Maria Kombinationspräparat von Vitamine E und Acetylsalicylate zur Behandlung und Prophylaxis des Atherosclerosis
CA2145229A1 (en) 1994-03-29 1995-09-30 Tetsuya Toge Suppressory compositions against hepatic metastases of tumors
US5554781A (en) * 1994-03-30 1996-09-10 Reierson; Robert L. Monoalkyl phosphonic acid ester production process
JPH07277988A (ja) 1994-04-05 1995-10-24 Senju Pharmaceut Co Ltd 局所用掻痒除去、治療剤
TW287103B (de) 1994-04-22 1996-10-01 Senju Pharma Co
JP3362501B2 (ja) 1994-04-28 2003-01-07 千寿製薬株式会社 角膜障害治療剤
JP3396953B2 (ja) 1994-05-10 2003-04-14 千寿製薬株式会社 網膜疾患予防・治療剤
US5589504A (en) * 1994-07-26 1996-12-31 Cornell Research Foundation, Inc. Treatment of newborn jaundice
CA2152693A1 (en) 1994-08-05 1996-02-06 Kazumi Ogata Therapeutic composition for pancreatitis
IT1274734B (it) 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
JPH0873338A (ja) * 1994-09-02 1996-03-19 Noevir Co Ltd 皮膚外用剤
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
FR2730928B1 (fr) * 1995-02-23 1997-04-04 Oreal Composition a base de vesicules lipidiques a ph acide et son utilisation en application topique
AU711716B2 (en) * 1995-04-21 1999-10-21 Sekisui Kagaku Kogyo Kabushiki Kaisha External preparations for treating dermatoses
US5607968A (en) * 1995-06-07 1997-03-04 Avon Products, Inc. Topical alkyl-2-O-L-ascorbyl-phosphates
WO1997014705A1 (fr) * 1995-10-17 1997-04-24 Showa Denko K.K. Phosphates de tocopherol tres purs, procedes de preparation, techniques d'analyse et produits cosmetiques correspondants
FR2741263B1 (fr) 1995-11-22 1997-12-26 Oreal Composition comprenant une dispersion aqueuse de vesicules lipidiques encapsulant un filtre uv a fonction acide et utilisations en application topique
NZ332426A (en) 1996-03-27 2000-09-29 Univ North Carolina Method of treating diseases involving dysfunction of ciliary movement such as ciliary dyskinesia and infertility with uridine triphosphates (UTP) and related compounds
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US5885595A (en) * 1996-05-13 1999-03-23 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic composition with a retinol fatty acid ester
CA2209690A1 (en) * 1996-07-31 1998-01-31 Sachiko Matsuura Therapeutic drug for acne vulgaris
JPH1067639A (ja) 1996-08-26 1998-03-10 Shiseido Co Ltd ビタミンｅ−ビタミンｃリン酸ジエステル／シクロデキストリン包接物及び該包接物を配合した皮膚外用剤
US6022867A (en) * 1996-11-27 2000-02-08 Showa Denko Kabushiki Kaisha Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals
JPH10155429A (ja) 1996-11-27 1998-06-16 Showa Denko Kk 動物に対するビタミンｅ供給方法および動物用トコフェロールリン酸エステル又はその塩類組成物
US6727280B2 (en) * 1997-01-07 2004-04-27 Sonus Pharmaceuticals, Inc. Method for treating colorectal carcinoma using a taxane/tocopherol formulation
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
US6932975B2 (en) 1997-01-29 2005-08-23 Kao Corporation Cosmetic composition comprising a phosphoric triester and a skin activating component
WO1998040069A2 (en) * 1997-03-13 1998-09-17 Hexal Ag Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations
US7179486B1 (en) * 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
DE19824983C2 (de) * 1997-06-04 2001-06-28 Pacific Corp 2-(3-Aminopropylphosphorsäure)-L-ascorbat, Verfahren zu seiner Herstellung und dieses enthaltende kosmetische Zubereitung zur Aufhellung der Haut
US5928631A (en) * 1997-06-09 1999-07-27 The Procter & Gamble Company Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins
US5906811A (en) * 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations
US5776915A (en) 1997-08-12 1998-07-07 Clarion Pharmaceuticals Inc. Phosphocholines of retinoids
US6096326A (en) * 1997-08-15 2000-08-01 Scandinavian-American Import/Export Corporation Skin care compositions and use
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
KR20010033811A (ko) * 1997-12-31 2001-04-25 토마스 안 빅토리아 2차 및 3차 아민을 함유하는 약제의 물에 용해가능한프로드럭 및 그것의 제조방법
WO1999039716A1 (en) 1998-02-03 1999-08-12 Senju Pharmaceutical Co., Ltd. Preventives and remedies for neuron digeneration-associated diseaseas
FR2777179A1 (fr) 1998-04-09 1999-10-15 Lvmh Rech Compositions cosmetiques ou dermatologiques comprenant un vehicule a base d'un liquide hydrophobe
US6461623B2 (en) * 1998-04-13 2002-10-08 Kao Corporation Cosmetic composition
JP4208209B2 (ja) 1998-06-22 2009-01-14 フジノン株式会社 コリメータレンズおよびこれを用いた光走査装置
US6121249A (en) * 1998-07-01 2000-09-19 Donald L. Weissman Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins
ATE399565T1 (de) * 1998-07-07 2008-07-15 Transdermal Technologies Inc Zusammensetzungen für die schnelle und nicht- irritierende transdermale verabreichung von pharmazeutika and verfahren zur formuliering davon und ihren verabreichung
JP2002526446A (ja) * 1998-09-23 2002-08-20 リサーチ ディベロップメント ファンデーション トロフェロール、トコトリエノール、その他のクロマン及び側鎖誘導体、並びにそれらの利用
US6703384B2 (en) * 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
US6770672B1 (en) * 1998-09-23 2004-08-03 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
US6153582A (en) 1998-11-05 2000-11-28 Bausch & Lomb Surgical, Inc. Defined serumfree medical solution for ophthalmology
US6048891A (en) * 1998-12-17 2000-04-11 Loma Linda University Medical Center Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of natriuretic disease
AUPP829399A0 (en) * 1999-01-25 1999-02-18 Swig Pty Ltd Recovery for chroman derivatives
AUPQ037499A0 (en) * 1999-05-14 1999-06-10 Swig Pty Ltd Improved process for phosphorylation and compounds produced by this method
JP2000212082A (ja) 1999-01-26 2000-08-02 Showa Denko Kk 皮膚用剤
US6156354A (en) * 1999-01-29 2000-12-05 Brandeis University Hyper-absorption of vitamin E dispersed in milks
US6184247B1 (en) * 1999-05-21 2001-02-06 Amway Corporation Method of increasing cell renewal rate
CA2375633C (en) * 1999-06-01 2014-03-18 Ocean Spray Cranberries, Inc. Cranberry seed oil extract and compositions containing components thereof
US6669951B2 (en) * 1999-08-24 2003-12-30 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
US6423742B1 (en) * 1999-09-02 2002-07-23 Drake Larson Compositions for reducing vascular plaque formation and methods of using same
KR20020059415A (ko) * 1999-09-27 2002-07-12 스티븐 씨. 큐웨이 토콜-가용성 치료요법제
JP2001169731A (ja) 1999-12-17 2001-06-26 Showa Denko Kk 動物体の脂質代謝改善剤
KR100847678B1 (ko) * 2000-02-11 2008-07-23 리서치 디벨럽먼트 파운데이션 토코페롤, 토코트리에놀, 다른 크로만 및 측쇄 유도체, 및이들의 용도
US20030035812A1 (en) * 2000-02-29 2003-02-20 Shinobu Ito Immune enhancement compositions and use thereof
US6346544B2 (en) * 2000-03-02 2002-02-12 Oklahoma Medical Research Foundation Desmethyl tocopherols for protecting cardiovascular tissue
JP2001247585A (ja) 2000-03-03 2001-09-11 Nof Corp トコフェロール誘導体、その中間体、その製造方法及び用途
US6444220B2 (en) * 2000-03-16 2002-09-03 Teresa S. Wiley Method and compositions for changing the contour of skin
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
US6485950B1 (en) * 2000-07-14 2002-11-26 Council Of Scientific And Industrial Research Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions
KR100365070B1 (ko) * 2000-08-29 2002-12-16 주식회사 태평양 토코페롤 유도체 및 그의 제조방법
JP4818500B2 (ja) * 2000-09-05 2011-11-16 株式会社ペンタプラストア トコトリエノール誘導体及びその製造方法
US20030206972A1 (en) * 2000-10-13 2003-11-06 Babish John G. Compositions containing carotenoids and tocotrienols and having synergistic antioxidant effect
ATE444756T1 (de) * 2000-11-14 2009-10-15 Vital Health Sciences Pty Ltd Zusammensetzungen umfassend komplexe von tocopherolphosphatderivaten
CN100396287C (zh) * 2000-11-14 2008-06-25 生命健康科学有限公司 含有电子转移剂磷酸盐衍生物的制剂
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
WO2002047680A2 (en) * 2000-12-15 2002-06-20 Galileo Laboratories, Inc. Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia
US20020151467A1 (en) * 2000-12-21 2002-10-17 Leung Frank K. Methods and compositions for oral insulin delivery
US20020131994A1 (en) * 2001-01-10 2002-09-19 Schur Henry B. Non-irritating formulation for the transdermal delivery of substances
US6849271B2 (en) * 2001-04-27 2005-02-01 Verion, Inc. Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods
TW576859B (en) * 2001-05-11 2004-02-21 Shipley Co Llc Antireflective coating compositions
KR100394770B1 (ko) 2001-06-05 2003-08-14 주식회사 태평양 토코페롤 유도체를 이용하여 나노유화입자를 안정화시키는방법 및 나노유화입자를 함유하는 피부 외용제 조성물
WO2003011303A1 (en) * 2001-07-27 2003-02-13 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
AUPR684801A0 (en) * 2001-08-06 2001-08-30 Vital Health Sciences Pty Ltd Supplement therapy
EP1429744A1 (de) * 2001-09-21 2004-06-23 Egalet A/S Polymeres freigabungssystem mit morphin
US20040234602A1 (en) * 2001-09-21 2004-11-25 Gina Fischer Polymer release system
AU2002951045A0 (en) * 2002-08-27 2002-09-12 Vital Health Sciences Pty Ltd Method of supplementing nascent endogenous storage forms
CA2458279A1 (en) * 2001-09-26 2003-04-03 Vital Health Sciences Pty Ltd. Modulation of vitamin storage
JP4370451B2 (ja) 2001-09-28 2009-11-25 大塚製薬株式会社 医薬組成物
JP2003128531A (ja) 2001-10-17 2003-05-08 Nonogawa Shoji Kk 皮膚外用剤
CA2466536C (en) * 2001-12-13 2012-02-07 Vital Health Sciences Pty Ltd Transdermal transport of compounds
JP3665904B2 (ja) 2002-01-31 2005-06-29 関西ティー・エル・オー株式会社 ヒトガン予防用組成物及びヒトガン予防方法
AU2003211131A1 (en) * 2002-02-14 2003-09-04 Sonus Pharmaceuticals, Inc. Metformin salts of lipophilic acids
US7074825B2 (en) * 2002-03-07 2006-07-11 Huanbiao Mo Composition and method for treating cancer
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US20040067890A1 (en) * 2002-10-04 2004-04-08 Gupta Shyam K. Ascorbic acid salts of organic bases with enhanced bioavailability for synergictic anti-aging and skin protective cosmetic compositions
US6645514B1 (en) * 2002-12-19 2003-11-11 Access Business Group International, Llc Increasing skin cell renewal with water-soluble Vitamin E
WO2004064831A1 (en) * 2003-01-17 2004-08-05 Vital Health Sciences Pty Ltd Compounds having anti-proliferative properties
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
AU2003901812A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphates of secondary alcohols
AU2003901813A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Pharmaceutical derivatives
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
US7207669B2 (en) * 2003-12-19 2007-04-24 Arizona Chemical Company Jet printing inks containing polymerized fatty acid-based polyamides
HRP20090363T1 (hr) * 2004-02-23 2009-08-31 Euro-Celtique S.A. Transdermalni injektor opioida rezistentan na zlouporabu
DK1720551T3 (da) 2004-03-03 2011-05-16 Vital Health Sciences Pty Ltd Alkaloidformuleringer
WO2006001473A1 (ja) 2004-06-29 2006-01-05 Japan Science And Technology Agency ヒアルロン酸を用いた小型肝細胞の選択的培養法および分離法
CA2575587C (en) * 2004-08-03 2014-06-17 Vital Health Sciences Pty Ltd Carrier for enteral administration
US20060120979A1 (en) * 2004-12-02 2006-06-08 Joel Rubin Skin care composition comprising hydroquinone and a substantially anhydrous base
US20090239827A1 (en) 2005-03-03 2009-09-24 Esra Ogru Compounds having lipid lowering properties
CA2599424A1 (en) 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
JP4270212B2 (ja) 2005-03-29 2009-05-27 セイコーエプソン株式会社 基板間隔調整装置、基板間隔調整方法、および液晶表示装置の製造方法
US20060228395A1 (en) * 2005-04-11 2006-10-12 Robert Lamb Vitamin E phosphate/phosphatidylcholine liposomes to protect from or ameliorate cell damage
NZ565049A (en) * 2005-06-17 2012-02-24 Vital Health Sciences Pty Ltd A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
KR100764679B1 (ko) * 2005-07-22 2007-10-09 익수제약 주식회사 파록세틴을 함유하는 경피투여용 패취제
US7446096B2 (en) * 2005-12-19 2008-11-04 Industrial Technology Research Institute Glutathione based delivery system
US20090005348A1 (en) * 2005-12-23 2009-01-01 Vital Health Sciences Pty Ltd Compounds Having Cytokine Modulating Properties
WO2008034178A1 (en) 2006-09-21 2008-03-27 Salvatore Iemma Topical depilating composition
JP5201858B2 (ja) 2007-03-26 2013-06-05 花王株式会社 遊離脂肪酸が低減された油脂の製造方法
FR2921259B1 (fr) * 2007-09-26 2015-02-13 Lvmh Rech Utilisation cosmetique du phosphate de tocopherol comme agent anti-vieillissement de la peau
EP2113242A1 (de) * 2008-05-02 2009-11-04 Pangaea Laboratories Limited Antioxidationsmittel für kosmetische, medizinische und pharmazeutische Zubereitungen
US20090297591A1 (en) 2008-05-30 2009-12-03 Orient Pharma Co., Ltd. Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
JP5132700B2 (ja) 2010-02-22 2013-01-30 三菱電機株式会社 手乾燥装置

Also Published As

Publication number Publication date
HK1098684A1 (en) 2007-07-27
EP1720551B9 (de) 2011-09-21
AU2005202477A1 (en) 2005-09-22
US8529947B2 (en) 2013-09-10
BRPI0508125A (pt) 2007-07-17
US20060281716A1 (en) 2006-12-14
EP1720551A4 (de) 2007-04-04
RU2006131997A (ru) 2008-04-10
DK1720551T3 (da) 2011-05-16
KR101173159B1 (ko) 2012-08-16
AU2005202477B2 (en) 2005-12-15
CA2557354C (en) 2013-05-07
EP1720551B1 (de) 2011-01-19
WO2005084678A1 (en) 2005-09-15
NZ549567A (en) 2009-10-30
JP4847437B2 (ja) 2011-12-28
DE602005025979D1 (de) 2011-03-03
KR20060130195A (ko) 2006-12-18
IL177781A (en) 2015-03-31
CA2557354A1 (en) 2005-09-15
JP2007526256A (ja) 2007-09-13
RU2477136C2 (ru) 2013-03-10
IL177781A0 (en) 2006-12-31
US20100209459A1 (en) 2010-08-19
EP1720551A1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
DK1720551T3 (da) Alkaloidformuleringer
ATE365740T1 (de) Substituierte pyrazolopyrimidine
TW200608977A (en) Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
WO2006078287A3 (en) Pde4b inhibitors and uses therefor
ATE302775T1 (de) Carbolinderivate
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
SG154433A1 (en) Phthalazine derivatives as parp inhibitors
TW200740815A (en) P38 MAP kinase inhibitors and methods for using the same
MY169515A (en) Quinazolinedione derivatives as parp inhibitors
ECSP066643A (es) PIRIDO [2,3-d] PIRIMIDINA-2,4-DIAMINAS COMO INHIBIDORES DE PDE 2
ATE338550T1 (de) Mikronisierter zolpidem hemitartrat
ATE346067T1 (de) Carbolinderivate
CR9750A (es) Dispersiones solidas amorfas de 7-cloro-n,n,5-trimetil-4-oxo-3-fenil-3,5-dihidro-4h-prirdazino[4,5-b]indol-1-acetamida
WO2005028474A3 (en) Pyrazoloquinoline derivatives as chk-1 inhibitors
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
DE60008400D1 (de) Triazolopyrimidinderivate
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
DK1742950T3 (da) Pyrazolo-[4,3-D]-pyrimidiner
UA97629C2 (ru) Фармацевтическая композиция, имеющая противоопухолевую активность, и способы
ATE335742T1 (de) Carbolinderivate als pdev inhibitoren
ATE246174T1 (de) Tosylprolin-derivate als thymidylat-synthase inhibitoren
BRPI0414873A (pt) derivados de imidazopiridina como inibidores de no-sintase induzìveis
ATE360422T1 (de) Tetrazyklische verbindungen als pde5-inhibitoren
SV2006002238A (es) Inhibidores de la adenilato ciclasa soluble ref. p-sv-78. 959/gh
BRPI0415038A (pt) derivados de imidazo (4,5-b) piridina como inibidores sem ser da sintase que podem ser induzidos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties